ANN ARBOR, Mich.--(BUSINESS WIRE)--Long Covid patients around the U.S. looking to participate in a clinical trial from home can sign up to be notified when an upcoming study conducted by scientists at ...
The Food and Drug Administration will no longer approve COVID-19 booster shots for healthy adults and children without new clinical trials proving they are safe and effective. COVID-19 booster ...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
A combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna, which is developing the experimental vaccine, announced Monday that in phase 3 clinical trials, mRNA ...
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct ...
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65, effectively limiting their availability later this ...
The Food and Drug Administration will issue guidelines requiring clinical trials prior to the approval of new COVID-19 boosters, a spokesperson confirmed to The Daily Signal. The FDA’s new framework ...
Dr. Michael Peluso, of the University of California, San Francisco, and his team are working to understand long COVID to help ...
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results